Biomarker analysis, such as C-reactive protein (CRP) and procalcitonin (PCT) testing, is a valuable tool for distinguishing bacterial from viral infections and optimizing antibiotic prescriptions [70], although there are no predefined cut-offs for these biomarkers to distinguish between viral and bacterial infections. This evidence concerns the gene CRP and viral infectious disease.